Royalty Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2020
Period Ending	Sep '25 Sep 10, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2020
Market Capitalization	13,464	10,948	11,306	16,312	15,050	15,881	Upgrade
Market Cap Growth	16.18%	-3.17%	-30.69%	8.38%	-5.23%	-	Upgrade
Enterprise Value	22,452	20,604	19,119	25,576	23,466	23,224	Upgrade
Last Close Price	30.27	23.90	23.80	33.48	32.74	-	Upgrade
PE Ratio	15.49	13.20	11.01	407.00	27.62	39.23	Upgrade
PS Ratio	6.86	5.01	5.31	7.79	7.48	9.15	Upgrade
PB Ratio	1.66	1.10	1.24	1.83	1.67	1.96	Upgrade
P/TBV Ratio	2.92	1.63	1.92	3.11	2.97	4.06	Upgrade
P/OCF Ratio	6.57	4.09	4.18	8.13	8.48	9.55	Upgrade
EV/Sales Ratio	11.41	9.42	8.98	12.22	11.66	13.39	Upgrade
EV/EBITDA Ratio	-	-	14.11	29.44	18.36	16.88	Upgrade
EV/EBIT Ratio	13.70	16.51	14.16	29.62	18.65	17.11	Upgrade
Debt / Equity Ratio	0.84	0.74	0.61	0.75	0.69	0.59	Upgrade
Debt / EBITDA Ratio	-	-	4.10	7.66	4.88	3.46	Upgrade
Asset Turnover	0.13	0.13	0.14	0.13	0.14	0.15	Upgrade
Quick Ratio	1.26	1.43	7.78	2.11	16.77	8.73	Upgrade
Current Ratio	1.26	1.44	7.90	2.19	16.81	8.76	Upgrade
Return on Equity (ROE)	17.29%	13.03%	17.34%	2.33%	12.32%	21.22%	Upgrade
Return on Assets (ROA)	6.49%	4.67%	5.62%	3.36%	5.33%	7.29%	Upgrade
Return on Capital (ROIC)	6.70%	4.73%	5.68%	3.39%	5.41%	7.38%	Upgrade
Return on Capital Employed (ROCE)	10.90%	7.60%	9.20%	5.90%	8.20%	10.60%	Upgrade
Earnings Yield	6.46%	7.58%	9.08%	0.25%	3.62%	5.02%	Upgrade
Dividend Yield	2.58%	3.40%	3.04%	2.12%	1.83%	-	Upgrade
Payout Ratio	40.13%	43.83%	31.57%	778.21%	46.02%	40.80%	Upgrade
Buyback Yield / Dilution	2.95%	1.46%	-37.66%	-5.59%	-10.48%	-	Upgrade
Total Shareholder Return	5.48%	4.85%	-34.62%	-3.46%	-8.65%	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.